Revenue
$4.1B
▲ 1.7% YoY
Net Income
$565.7M
▼ 28.3% YoY
EPS
$2.49
▼ 25.0% YoY
Cash
$2.0B
▼ 9.3% YoY
FY 2025 · As of 2025-09-27
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Liddy Anne M. General Counsel | Sell tax | Feb 27, 2026 | 185 | $75.36 | $14K | Form 4 ↗ |
Wendell Amy McBride Director | Grant | Feb 26, 2026 | 3.2K | - | - | Form 4 ↗ |
Stewart Stacey D. Director | Grant | Feb 26, 2026 | 3.2K | - | - | Form 4 ↗ |
Stamoulis Christiana Director | Grant | Feb 26, 2026 | 3.2K | - | - | Form 4 ↗ |
Mohtashami Nanaz Director | Grant | Feb 26, 2026 | 3.2K | - | - | Form 4 ↗ |
McMillan Wayde D. Director | Grant | Feb 26, 2026 | 3.2K | - | - | Form 4 ↗ |
Madaus Martin D Director | Grant | Feb 26, 2026 | 3.2K | - | - | Form 4 ↗ |
HANTSON LUDWIG Director | Grant | Feb 26, 2026 | 3.2K | - | - | Form 4 ↗ |
Dockendorff Charles J Director | Grant | Feb 26, 2026 | 3.2K | - | - | Form 4 ↗ |
Horvath Mark W. President, Breast & Skeletal | Sell tax | Feb 10, 2026 | 113 | $75.15 | $8K | Form 4 ↗ |
De Walt Diana SVP, Human Resources | Sell tax | Jan 30, 2026 | 4.4K | $74.93 | $331K | Form 4 ↗ |